View |
|
DR-XY41156
|
Poractant Alfa
|
Curosurf
|
80mg/mL
|
Sterile Suspension (Intratracheal/Intrabronchial)
|
Porcine Pulmonary Surfactant
|
Chiesi Farmaceutici
|
Italy
|
Initial (from Monitored Release Extension)
|
30 May 2022
|
04 September 2025
|
View |
|
DR-XY41161
|
Co-Amoxiclav
|
Nahaltin
|
875 mg/125 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co. Ltd.
|
China
|
initial (Variation)
|
20 September 2022
|
20 September 2027
|
View |
|
DR-XY41164
|
Nebivolol (as hydrochloride)
|
Nebil
|
2.5mg
|
Tablet
|
Beta Blocking Agent
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
Initial (from Monitored Release (MR) status)
|
06 June 2022
|
16 August 2025
|
View |
|
DR-XY41170
|
Losartan Potassium + Hydrochlorothiazide
|
Lozaar Plus
|
100 mg/12.5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
17 August 2022
|
17 August 2027
|
View |
|
DR-XY41173
|
Calcium folinate
|
Lovorin
|
10 mg / mL (50 mg/ 5 mL)
|
Solution for Injection (IM/IV)
|
Detoxifying agent for neoplastic treatment
|
Beacon Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
05 August 2022
|
22 August 2027
|
View |
|
DR-XY41176
|
Paracetamol + Phenypropanolamine Hydrochloride + Chlorphenamine Maleate
|
Coldzep Gold
|
325 mg/25 mg/2 mg
|
Tablet
|
Analgesic/ Antipyretic/ Nasal Decongestant/ Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 July 2022
|
28 August 2027
|
View |
|
DR-XY41177
|
Butamirate Citrate
|
Cofmed
|
7.5 mg/5 mL
|
Syrup
|
Antitussives
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
15 August 2022
|
28 August 2027
|
View |
|
DR-XY41180
|
Diclofenac Sodium
|
Dolfen
|
25 mg/mL (75 mg/3 mL)
|
Solution For Injection
|
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Automatic Renewal
|
08 July 2022
|
28 August 2027
|
View |
|
DR-XY41189
|
Ascorbic Acid + Zinc
|
Orazinc Plus
|
100 mg/4.2 mg per mL
|
Syrup (Oral Drops)
|
Vitamin and Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
04 August 2022
|
10 September 2027
|
View |
|
DR-XY41191
|
Fluorouracil
|
Fucil
|
50 mg / mL (500 mg/ 10 mL)
|
Solution for Injection/ Infusion (IV)
|
Antineoplastic (Pyrimidine analogue)
|
Beacon Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
25 August 2022
|
04 September 2027
|
View |
|
DR-XY41202
|
Mometasone Furoate
|
Elicort
|
1mg/g (0.1% w/w)
|
Cream
|
Corticosteroid
|
Dongkwang Pharm. Co., Ltd.
|
Korea
|
Renewal
|
21 June 2022
|
04 September 2027
|
View |
|
DR-XY41203
|
Minocycline (As Hydrochloride)
|
Haicin
|
50mg
|
Capsule
|
Antibacterial (Tetracycline)
|
Haikou Pharmaceutical Factory Co., Ltd.
|
China
|
Renewal
|
18 April 2022
|
04 September 2027
|
View |
|
DR-XY41204
|
CLINDAMYCIN (AS HYDROCHLORIDE)
|
TORODA
|
300MG
|
CAPSULE
|
ANTIBACTERIAL (LINCOSAMIDE)
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
Renewal
|
17 August 2022
|
11 September 2027
|
View |
|
DR-XY41205
|
Hyoscine N-Butylbromide
|
Buscopan
|
10mg
|
Tablet
|
Antispasmodic
|
PT Boehringer Ingelheim Indonesia
|
Indonesia
|
Renewal
|
21 June 2022
|
13 September 2027
|
View |
|
DR-XY41208
|
Nalbuphine Hydrochloride
|
Nalbulin
|
10mg/mL
|
Solution For Injection
|
Opioid Analgesic
|
Global Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
13 April 2022
|
04 September 2027
|
View |
|
DR-XY41209
|
Triamcinolone Acetonide
|
Trinolone
|
1mg/g (0.1% w/w)
|
Cream
|
Corticosteriod
|
Dongkwang Pharm. Co., Ltd.
|
Korea
|
Automatic Renewal
|
08 July 2022
|
05 September 2027
|
View |
|
DR-XY41210
|
Ketamine
|
Ketarol
|
1mg/mL
|
Solution For Injection
|
General Anesthetic
|
Global Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
Automatic Renewal
|
07 April 2022
|
11 September 2027
|
View |
|
DR-XY41215
|
Pregabalin
|
Funxion
|
75 mg
|
Capsule
|
Antiepileptic
|
Ajanta Pharma Limited
|
India
|
Initial (from Monitored Release Extension)
|
19 September 2022
|
11 September 2025
|
View |
|
DR-XY41216
|
Pregabalin
|
Funxion
|
150 mg
|
Capsule
|
Antiepileptic
|
Ajanta Pharma Ltd.
|
India
|
Initial [from Monitored Release]
|
30 May 2022
|
11 September 2025
|
View |
|
DR-XY41217
|
Amisulpride
|
Amiabel
|
400 mg
|
Film-Coated Tablet
|
Antipyschotics (Benzamides)
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 September 2022
|
19 September 2027
|